228 related articles for article (PubMed ID: 31850822)
1. Radiation induces an inflammatory response that results in STAT3-dependent changes in cellular plasticity and radioresistance of breast cancer stem-like cells.
Arnold KM; Opdenaker LM; Flynn NJ; Appeah DK; Sims-Mourtada J
Int J Radiat Biol; 2020 Apr; 96(4):434-447. PubMed ID: 31850822
[No Abstract] [Full Text] [Related]
2. Keap1-Nrf2 Pathway Regulates ALDH and Contributes to Radioresistance in Breast Cancer Stem Cells.
Kamble D; Mahajan M; Dhat R; Sitasawad S
Cells; 2021 Jan; 10(1):. PubMed ID: 33419140
[TBL] [Abstract][Full Text] [Related]
3. Esculentoside A suppresses breast cancer stem cell growth through stemness attenuation and apoptosis induction by blocking IL-6/STAT3 signaling pathway.
Liu C; Dong L; Sun Z; Wang L; Wang Q; Li H; Zhang J; Wang X
Phytother Res; 2018 Nov; 32(11):2299-2311. PubMed ID: 30080291
[TBL] [Abstract][Full Text] [Related]
4. LncRNA XIST regulates breast cancer stem cells by activating proinflammatory IL-6/STAT3 signaling.
Ma Y; Zhu Y; Shang L; Qiu Y; Shen N; Wang J; Adam T; Wei W; Song Q; Li J; Wicha MS; Luo M
Oncogene; 2023 May; 42(18):1419-1437. PubMed ID: 36922677
[TBL] [Abstract][Full Text] [Related]
5. IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer.
Gao W; Wen H; Liang L; Dong X; Du R; Zhou W; Zhang X; Zhang C; Xiang R; Li N
Theranostics; 2021; 11(6):2564-2580. PubMed ID: 33456560
[No Abstract] [Full Text] [Related]
6. Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44⁺ human breast cancer cells.
Croker AK; Allan AL
Breast Cancer Res Treat; 2012 May; 133(1):75-87. PubMed ID: 21818590
[TBL] [Abstract][Full Text] [Related]
7. IL-6 enriched lung cancer stem-like cell population by inhibition of cell cycle regulators via DNMT1 upregulation.
Liu CC; Lin JH; Hsu TW; Su K; Li AF; Hsu HS; Hung SC
Int J Cancer; 2015 Feb; 136(3):547-59. PubMed ID: 24947242
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.
Lin C; Wang L; Wang H; Yang L; Guo H; Wang X
J Cell Biochem; 2013 Sep; 114(9):2061-70. PubMed ID: 23553622
[TBL] [Abstract][Full Text] [Related]
9. Nanog Signaling Mediates Radioresistance in ALDH-Positive Breast Cancer Cells.
Dehghan Harati M; Rodemann HP; Toulany M
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845764
[TBL] [Abstract][Full Text] [Related]
10. STAT3 as a potential therapeutic target in ALDH+ and CD44+/CD24+ stem cell-like pancreatic cancer cells.
Lin L; Jou D; Wang Y; Ma H; Liu T; Fuchs J; Li PK; Lü J; Li C; Lin J
Int J Oncol; 2016 Dec; 49(6):2265-2274. PubMed ID: 27748818
[TBL] [Abstract][Full Text] [Related]
11. Oct4 suppresses IR‑induced premature senescence in breast cancer cells through STAT3- and NF‑κB-mediated IL‑24 production.
Kim JY; Kim JC; Lee JY; Park MJ
Int J Oncol; 2018 Jul; 53(1):47-58. PubMed ID: 29749438
[TBL] [Abstract][Full Text] [Related]
12. Dihydrotanshinone-Induced NOX5 Activation Inhibits Breast Cancer Stem Cell through the ROS/Stat3 Signaling Pathway.
Kim SL; Choi HS; Kim JH; Jeong DK; Kim KS; Lee DS
Oxid Med Cell Longev; 2019; 2019():9296439. PubMed ID: 31019654
[TBL] [Abstract][Full Text] [Related]
13. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
14. Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1.
Lee JH; Choi SI; Kim RK; Cho EW; Kim IG
Sci Rep; 2018 Jul; 8(1):10711. PubMed ID: 30013043
[TBL] [Abstract][Full Text] [Related]
15. Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3.
Thomas ML; de Antueno R; Coyle KM; Sultan M; Cruickshank BM; Giacomantonio MA; Giacomantonio CA; Duncan R; Marcato P
Mol Oncol; 2016 Nov; 10(9):1485-1496. PubMed ID: 27592281
[TBL] [Abstract][Full Text] [Related]
16. STAT3 signaling pathway is necessary for cell survival and tumorsphere forming capacity in ALDH⁺/CD133⁺ stem cell-like human colon cancer cells.
Lin L; Fuchs J; Li C; Olson V; Bekaii-Saab T; Lin J
Biochem Biophys Res Commun; 2011 Dec; 416(3-4):246-51. PubMed ID: 22074823
[TBL] [Abstract][Full Text] [Related]
17. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line.
Ortiz-Montero P; Londoño-Vallejo A; Vernot JP
Cell Commun Signal; 2017 May; 15(1):17. PubMed ID: 28472950
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis.
Wang X; Sun W; Shen W; Xia M; Chen C; Xiang D; Ning B; Cui X; Li H; Li X; Ding J; Wang H
J Hepatol; 2016 Jun; 64(6):1283-94. PubMed ID: 26812074
[TBL] [Abstract][Full Text] [Related]
19. Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells.
Debeb BG; Cohen EN; Boley K; Freiter EM; Li L; Robertson FM; Reuben JM; Cristofanilli M; Buchholz TA; Woodward WA
Breast Cancer Res Treat; 2012 Jul; 134(2):495-510. PubMed ID: 22547109
[TBL] [Abstract][Full Text] [Related]
20. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
